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The unique immunological riddle of human gestation involves a
broad variety of cells and molecules playing evidently important
roles (1). The reproductive and immune systems are morphologi-
cally diffused,and their modus operandi involves widely distributed
signals in response to the given environmental input, while both
systems must interact to obtain their normal functionality (2). Fur-
thermore, dysregulation of physiological interactions between the
two systems can lead to severe pregnancy-related disorders or com-
plications, such as fetal loss, preterm labor, preeclampsia (PE), and
poor fetal development (3). On the other hand, by ameliorating
autoimmune conditions such as multiple sclerosis and rheumatoid
arthritis, while other conditions such as systemic lupus are dete-
riorated, pregnancy as a condition may provide a unique insight
into novel immunomodulatory strategies (4, 5).
The scientific focus on reproductive–immune research has
historically provided substantial understanding of the inter-
face between these two physiological systems. With such recent
progress in the field, we felt that it is valuable and well-timed to
review the broad variety of the relevant physiologic and pathologic
aspects – from menstruation to fertilization and implantation,
and from placentation and pregnancy per se to the post partum
condition – in which the immune system takes part.
As editors, we are delighted by the keen response of 15 groups
of scientists from 4 different continents, which kindly contributed
their unique expertise to our effort to recap, value, and extend
our insights concerning the field of reproductive immunology. We
sincerely hope that the present eBook will succeed to share with
the reader the broad and vivid discussion between the authors and
editors.
Schumacher et al. (6) explore the interplay between the
endocrine and immune systems during gestation, with focus on
progesterone,estradiol, and human chorionic gonadotropin. Preg-
nancy hormones are critically for the successful establishment,
maintenance, and completion of pregnancy. They suppress detri-
mental maternal alloresponses while promoting tolerance path-
ways through the antigen-presenting capacity of DCs, monocytes,
and macrophages as well as the blockage of NK, T, and B cells.
These findings highlight the importance of endocrine factors for
tolerance induction during pregnancy.
Hsu and Nanan (7) discuss the recent advances in the complex
crosstalk between the innate and adaptive immune system during
human pregnancy and PE. They present many lines of evidence
supporting an immunological origin to PE, implicating decid-
ual NK cells and APC DCs and macrophages as major players in
the regulation of vascular remodeling and trophoblast invasion.
On the other hand, within the adaptive immune system, Foxp3+
Tregs and CD4+HLA-G+ suppressor T-cells seem to be essential
for guaranteeing immune tolerance.
Getting deeper into the mechanisms of placental pathology,
Faas et al. (8) focus on the role of monocytes and macrophages in
pregnancy and PE. Given the generalized activation of the acute
inflammatory response, monocytes may play a central role in this
reaction, since they are short-lived cells that mature in the circula-
tion and transmigrate into affected tissues upon an inflammatory
stimulus, developing into macrophages. Macrophages in turn are
abundant in the endometrium and play a crucial part in implan-
tation and placentation. In PE, these macrophages appear to be
activated and in larger numbers.
In the same context, Ruocco et al. (9) provide insight concern-
ing the role of Tregs in pregnancy reassessing the original concept
of “suppressor T-cells” in pregnancy, putting it in a historical per-
spective, and highlighting the main data revising the concept of
Tregs in gestation. Moreover, they focus to the most important
questions in the field, such as Treg antigen specificity, Treg subsets,
the functional crosstalk of Tregs with NK and DCs.
Joerger-Messerli et al. in Basel (10) observed that the inflam-
matory reaction in monocytes is initiated by the interaction of
syncytiotrophoblast microparticles (STBM) with TLRs, which in
turn signal through NF-κB to mediate the transcription of pro-
inflammatory mediators. Since pregnancy is accompanied by a
mild systemic inflammatory response, they show that in vitro gen-
erated STBM from normal placentas stimulate monocytes. Fur-
thermore, STBM derived from PE placentas up-regulated CD54
expression, and stimulated IL-6 and IL-8 secretion in a dose-
dependent manner, which was impaired in the presence of TLR
signaling inhibitors or when blocking NF-κB activation.
Fettke et al. (11) examine B cell involvement in the immune
response against paternal antigens and tolerance mechanisms.
Such pleiotropic cells play a considerable role by secreting
immunomodulatory IL-10, while they can harm pregnancy due to
their capacity to produce autoantibodies. New evidence in mouse
models suggests that IL-10 producing B cells (B10), contribute
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in maintaining tolerance, fighting danger signals at the fetal–
maternal interface. In human pregnancies, B10 cells increase with
onset but not in case of spontaneous abortions, suppressing TNF-α
production by T-cells.
A review on the unique neonatal NK cell population and its
role in gestational autoimmunity is provided by Rival et al. (12)
from Kenneth Tung’s group. Maternal autoantibodies can trigger
autoimmune ovarian disease (AOD) in the progeny of women with
SLE or Sjogren’s syndrome. The pathogenic effect of autoantibody
exposure is investigated in mice, in which immune complexes are
formed in adult and neonatal ovaries, but a specific Ab-species
triggers severe AOD only in young mice. Propensity to AOD is due
to the uniquely hyper-responsive neonatal NK cells. Resistance to
AOD in older mice results from specific NK cells that regulate
effector NK cells and Tregs. Activated by ovarian immune com-
plexes, NKs migrate to lymphoid organs where priming occurs.
These insights uncover new properties of the neonatal innate and
adaptive responses, lethality of premature infant infection, and
novel neonatal antiviral vaccine design.
Woidacki et al. (13) summarize the existing knowledge con-
cerning the course of pregnancy in women affected by mast
cell (MC) mediated or associated disorders. While physiological
numbers of MCs influence positively the outcome of pregnancy,
uncontrolled augmentations in quantity and activation can lead
to dangerous complications. Women with the desire of getting
pregnant and diagnosed with MC mediated disorders – urticaria,
mastocytosis, or MC-related chronic inflammatory diseases – may
benefit from specialized medical support to ensure a positive
pregnancy outcome.
Than et al. (14) provide evidence concerning the protective role
of placental protein 13 (PP13), an immunoregulatory galectin.
Three of the five human galectins are expressed in the placenta,
and galectin-13 (PP13) is predominantly expressed by the syn-
cytiotrophoblast and released from the placenta into the circu-
lation. Its ability to induce apoptosis of T-cells in vitro and to
kill T-cells and macrophages in the maternal decidua, suggests
important immune functions. Indeed, LGALS13 mutations and
decreased placental expression of PP13 and its low concentra-
tions during first trimester are associated with elevated risk of
PE. PP13 turned to be a good early biomarker to assess mater-
nal risk for the subsequent development of pregnancy compli-
cations, which might enable its potential in directing patient
management.
Sedlmayr et al. (15) highlight the role of tryptophan catabo-
lism in the placenta, focusing mainly on the role of indoleamine
2,3-dioxygenase-1 (IDO1), one of three enzymes involved in the
tryptophan degradation pathway. IDO1 has been implicated in
regulation of feto-maternal tolerance in the mouse. Depletion of
tryptophan mediates immunoregulation and antimicrobial func-
tions. In addition to the decidual glandular epithelium, IDO1
is localized in the vascular endothelium of the chorion and the
endothelium of the decidual spiral arteries. Possible consequences
of tryptophan catabolism in the endothelium are relaxation of
the placental vasotonus, contributing to placental perfusion and
growth of both placenta and fetus.
Chatterjee et al. (16) from the Mitchell lab examine how
immune cells that produce IL-4 and IL-10 are regulated
throughout pregnancy and the effects of reduced IL-4 and IL-
10 signaling on fetal and maternal physiology. The resolution of
inflammation plays an important role throughout pregnancy and
is largely mediated by immune cells producing IL-4 and IL-10.
The temporal and spatial aspects of reducing inflammation during
pregnancy are thoroughly discussed.
Perez-Sepulveda et al. (17) discuss the involvement of the innate
immune system in the establishment of an environment that favors
pregnancy and possible alterations related to the development of
PE. Since normal pregnancy is considered as a Th2 immunological
state, PE has been classically described as a Th1/Th2 imbalance;
recent studies have expanded the Th1/Th2 into a Th1/Th2/Th17
and regulatory T-cells paradigm and where DCs could have a
crucial role.
An insight into the impact of bacterial infections, such as Heli-
cobacter pylori (HP), in PE is delivered by Tersigni et al. (18). Since
the primary trigger of PE is unknown, a hypothesis concerning
the disease onset is triggering by infectious agents. Consistently,
higher seroprevalence of HP infection is evident in women with
PE. As trophoblast invasion is a crucial step in implantation and
placental development, the proposed infection-induced autoim-
mune mechanism, interfering negatively with the fetal side of the
developing placenta, may explain the higher seropositivity for HP
infection PE cases.
Nilsson et al. (19) discuss the role of the human HLA-Ib pro-
tein (HLA-G) in the regulation of the immunological crosstalk
during conception and pregnancy: from genetics to physiolog-
ical effects, from pregnancy and pregnancy complications to a
short discussion on future possible means of preventative mea-
sures and therapies. As HLA-G expression is limited to ges-
tation, it is proposed as a key player in the maintenance of
immunological tolerance. HLA-G might be involved in immune
processes even before conception, since HLA-G is detected in non-
pregnant women genital tract and blood, in men’s seminal fluid,
and in the pre-implanted embryo. Therefore, a combined con-
tribution from the mother, the father, and the embryo/fetus is
important.
The series of articles included in the present collection is
completed with a commentary by Khoury et al. (20) on the
promising potential of menstrual stem cells for antenatal diag-
nosis and cell therapy. Menstrual-derived stem cells (MenSCs)
are a new source of MSC isolated from the menstrual fluid.
Currently, there is a growing interest in their clinical potential
due to their multipotency, high proliferative capacity, and facile
way to obtain non-invasively. This review details their distinctive
biological properties regarding immunophenotype and function,
proliferation/differentiation potential, and paracrine effects. Their
possible role in antenatal diagnosis is also discussed.
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